Loading
Latest filing published 28 May 2021 for Genesis Healthcare, Inc., €13k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Paul David Bach is a declared insider of Genesis Healthcare, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 30 May 2017 to 15 May 2021, the count stands at 16 filings.
Every open-market trade on record is a sale: 9 sales worth €96k. Other entries cover 5 share grants.
The latest filing, published on 28 May 2021, reports a share grant of €13k in Genesis Healthcare, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration